CATALOGO DEI PRODOTTI DELLA RICERCA

Granata, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.400
EU - Europa 2.897
AS - Asia 1.888
SA - Sud America 275
Continente sconosciuto - Info sul continente non disponibili 142
AF - Africa 36
OC - Oceania 5
Totale 8.643
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.284
RU - Federazione Russa 1.074
SG - Singapore 676
CN - Cina 583
GB - Regno Unito 575
IT - Italia 366
SE - Svezia 210
BR - Brasile 206
VN - Vietnam 197
FR - Francia 180
HK - Hong Kong 144
IE - Irlanda 137
DE - Germania 128
FI - Finlandia 89
KR - Corea 61
CA - Canada 48
BD - Bangladesh 36
ID - Indonesia 36
IN - India 34
AR - Argentina 28
UA - Ucraina 28
TR - Turchia 27
AT - Austria 19
BE - Belgio 18
MX - Messico 18
JP - Giappone 16
IQ - Iraq 12
NL - Olanda 12
ZA - Sudafrica 12
EC - Ecuador 11
PL - Polonia 11
CO - Colombia 9
CR - Costa Rica 9
ES - Italia 9
GT - Guatemala 9
SV - El Salvador 9
PK - Pakistan 8
RO - Romania 7
IL - Israele 6
MY - Malesia 6
UZ - Uzbekistan 6
VE - Venezuela 6
AU - Australia 5
CH - Svizzera 5
CL - Cile 5
HN - Honduras 5
PY - Paraguay 5
MA - Marocco 4
NG - Nigeria 4
PH - Filippine 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NI - Nicaragua 3
NP - Nepal 3
OM - Oman 3
PR - Porto Rico 3
RS - Serbia 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MT - Malta 2
PE - Perù 2
PS - Palestinian Territory 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
KY - Cayman, isole 1
Totale 8.495
Salva come PNG Salva come JPEG
Città #
Southend 487
Ashburn 459
Singapore 370
Moscow 369
Chandler 360
San Jose 314
Dallas 181
Jacksonville 156
Hong Kong 141
Dublin 133
Beijing 115
Council Bluffs 112
Ann Arbor 108
Woodbridge 96
New York 95
Verona 91
Los Angeles 60
Wilmington 56
Lawrence 50
Princeton 50
The Dalles 50
Houston 47
Dong Ket 40
Santa Clara 38
Jinan 36
Redmond 36
Ho Chi Minh City 35
Buffalo 34
Columbus 32
Hanoi 31
Nanjing 28
Redondo Beach 28
Shenyang 27
São Paulo 24
Seattle 23
Helsinki 22
Rome 22
Atlanta 20
Hebei 20
Jakarta 20
Tianjin 20
Orem 18
Brussels 17
Kent 17
Munich 17
Sindelfingen 17
Tokyo 16
Boardman 15
Milan 15
Ningbo 15
Lancaster 14
Vienna 14
Denver 13
Taizhou 13
Brooklyn 12
Changsha 12
Phoenix 12
Montreal 11
Padova 11
Zhengzhou 11
Bologna 10
Chicago 10
Guangzhou 10
Jiaxing 10
San Francisco 10
Seoul 10
Ankara 9
Nanchang 9
Rio de Janeiro 9
Toronto 9
Auburn Hills 8
Boston 8
Charlotte 8
Haikou 8
Hangzhou 8
Nuremberg 8
Porto Alegre 8
Quito 8
Redwood City 8
San José 8
Washington 8
Barnet 7
Biên Hòa 7
London 7
Manchester 7
North Bergen 7
San Salvador 7
Taiyuan 7
Turin 7
Turku 7
Amsterdam 6
Baghdad 6
Chennai 6
Florence 6
Frankfurt am Main 6
Johannesburg 6
Venice 6
Warsaw 6
Cambridge 5
Da Nang 5
Totale 5.011
Salva come PNG Salva come JPEG
Nome #
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 308
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 272
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 267
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 214
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 211
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 202
mTOR inhibitors and renal allograft: Yin and Yang. 198
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 198
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 196
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 196
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 194
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 193
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 193
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 191
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 189
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 188
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 186
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 185
DISTURBI PSICOLOGICI, QUALITÀ DI VITA E PRODUZIONE DI CITOCHINE NEI PAZIENTI IN EMODIALISI 183
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 181
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 179
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 176
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 176
Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. 174
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 173
Dialysis-related systemic microinflammation is associated with specific genomic patterns 173
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 171
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 169
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 166
mTOR Inhibition Role in Cellular Mechanisms 164
Mitochondria: a new therapeutic target in chronic kidney disease. 163
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 160
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 160
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 159
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 159
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 159
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 159
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 156
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 150
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 149
Analysis of urinary exosomes applications for rare kidney disorders. 146
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 145
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 141
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 141
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 121
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 114
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 114
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. 107
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 92
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 82
Totale 8.643
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.462
article - articoli 27.013
book - libri 0
conference - conferenze 2.449
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.924
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022220 0 0 0 0 8 17 28 31 12 9 25 90
2022/20231.002 62 140 83 172 85 228 8 51 119 6 32 16
2023/2024450 23 39 49 40 57 81 9 40 3 10 82 17
2024/20251.054 52 67 47 202 49 37 68 52 152 50 98 180
2025/20263.348 225 136 173 561 861 247 308 167 177 214 59 220
2026/2027534 47 73 110 292 12 0 0 0 0 0 0 0
Totale 8.643